Adalimumab Treatment for SAPHO Syndrome

被引：25

作者：

Arias-Santiago, Salvador ^{[1
]}

Sanchez-Cano, Daniel ^{[2
]}

Luis Callejas-Rubio, Jose ^{[2
]}

Antonia Fernandez-Pugnaire, Maria ^{[1
]}

Ortego-Centeno, Norberto ^{[2
]}

机构：

[1] Univ Granada, San Cecilio Clin Hosp, Dept Dermatol, ES-18012 Granada, Spain

[2] Univ Granada, San Cecilio Clin Hosp, Dept Internal Med, ES-18012 Granada, Spain

来源：

ACTA DERMATO-VENEREOLOGICA | 2010年 / 90卷 / 03期

关键词：

ANTI-TNF-ALPHA; RHEUMATOID-ARTHRITIS; INFLIXIMAB; NEUTROPHILS; BLOCKING; OSTEITIS; THERAPY;

D O I：

10.2340/00015555-0822

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：301 / 302

页数：2

共 11 条

[1] Infliximab treatment shifts the balance between stimulatory and inhibitory Fcγ receptor type II isoforms on Neutrophils in patients with rheumatoid arthritis [J].

Belostocki, Kristina ;

Pricop, Luminita ;

Redecha, Patricia B. ;

Aydin, Ani ;

Leff, Linda ;

Harrison, Melanie J. ;

Salmon, Jane E. .

ARTHRITIS AND RHEUMATISM, 2008, 58 (02) :384-388

[2]

BENHAMOU CL, 1988, CLIN EXP RHEUMATOL, V6, P109

[3]

CHAMOT AM, 1987, REV RHUM, V54, P187

[4] THE SAPHO SYNDROME [J].

KAHN, MF ;

KHAN, MA .

BAILLIERES CLINICAL RHEUMATOLOGY, 1994, 8 (02) :333-362

[5] Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-α antagonists [J].

Lee, H-H. ;

Song, I-H. ;

Friedrich, M. ;

Gauliard, A. ;

Detert, J. ;

Roewert, J. ;

Audring, H. ;

Kary, S. ;

Burmester, G. -R. ;

Sterry, W. ;

Worm, M. .

BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (03) :486-491

[6] In SAPHO syndrome anti-TNF-α therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations [J].

Massara, A. ;

Cavazzini, P. L. ;

Trotta, F. .

RHEUMATOLOGY, 2006, 45 (06) :730-733

[7] The membrane proteinase 3 expression on Neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis [J].

Matsumoto, Takeshi ;

Kaneko, Toshihiro ;

Seto, Masashi ;

Wada, Hideo ;

Kobayashi, Toshihiko ;

Nakatani, Kaname ;

Tonomura, Harue ;

Tono, Yasutaka ;

Ohyabu, Mariko ;

Nobori, Tsutomu ;

Shiku, Hiroshi ;

Sudo, Akihiro ;

Uchida, Atsumasa ;

Kurosawa, Deborah J. Stearns ;

Kurosawa, Shinichiro .

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2008, 14 (02) :186-192

[8] Ilium osteitis as the main manifestation of the SAPHO syndrome:: Response to infliximab therapy and review of the literature [J].

Moll, Concepcion ;

Hernandez, M. Victoria ;

Canete, Juan D. ;

Gomez-Puerta, Jose A. ;

Soriano, Alex ;

Collado, Antonio ;

Sarimarti, Raimon .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 37 (05) :299-306

[9] Chimerical anti-TNF-α, infliximab, inhibits neutrophil chemotaxis and production of reactive oxygen species by blocking the priming effect of mononuclear cells on neutrophils [J].

Pay, S ;

Musabak, U ;

Erdem, H ;

Simsek, I ;

Pekel, A ;

Sengul, A ;

Dinc, A .

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2005, 27 (02) :187-198

[10] Sustained response to tumor necrosis factor α-blocking agents in two patients with SAPHO syndrome [J].

Wagner, AD ;

Andresen, J ;

Jendro, MC ;

Hülsemann, JL ;

Zeidler, H .

ARTHRITIS AND RHEUMATISM, 2002, 46 (07) :1965-1968

← 1 2 →